FDA Withdraws Approval of Two New Animal Drug Applications for Tylosin

Summary

The US Food and Drug Administration (FDA) is amending its animal drug regulations to remove the approval of two new animal drug applications (NADAs) for Tylosin, following a notice published in the Federal Register.